Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +49.85%
#3 DOVU DOVU +47.86%
#4 Velvet Velvet +43.76%
#5 Black Phoenix Black Phoenix +34.36%
#6 Cross Cross +21.02%
#7 Perle Perle +19.03%
#8 τemplar τemplar +16.86%
#9 Cysic Cysic +15.93%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.88%
Coin of the day
Glidr Glidr
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Chimeric Therapeutics Limited Chimeric Therapeutics Limited

Chimeric Therapeutics Limited

CHM
Rang in aandelen #38382
Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical... Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.
Aandeelprijs
$0.02468497
Marktkapitalisatie
$1.01M
Verandering (1 dag)
-12.50%
Verandering (1 jaar)
-87.34%
Land
AU
Handel Chimeric Therapeutics Limited (CHM)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Chimeric Therapeutics Limited (CHM)
Het dividendrendement (TTM) van Chimeric Therapeutics Limited (aandelsymbool: CHM) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Chimeric Therapeutics Limited (CHM) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE